SPONSOR
Nanjing First Hospital, Nanjing Medical University
Total Trials
3
Recruiting
3
Phases
Phase 4
Conditions studied: Neuroblastoma (NB)HELICOBACTER PYLORI INFECTIONSMetabolic SyndromeNeuroblastomaPheochromocytomaParaganglioma
Nanjing First Hospital, Nanjing Medical University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Neuroblastoma (NB), HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome, Neuroblastoma.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nanjing First Hospital, Nanjing Medical University
How many clinical trials has Nanjing First Hospital, Nanjing Medical University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Nanjing First Hospital, Nanjing Medical University, of which 3 are actively recruiting participants. These trials cover conditions including Neuroblastoma (NB), HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanjing First Hospital, Nanjing Medical University research focus on?
Nanjing First Hospital, Nanjing Medical University clinical trials span Neuroblastoma (NB), HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome, Neuroblastoma, Pheochromocytoma, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nanjing First Hospital, Nanjing Medical University clinical trial?
To participate in a Nanjing First Hospital, Nanjing Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanjing First Hospital, Nanjing Medical University trials with current recruitment status updated daily.
Clinical Trials by Nanjing First Hospital, Nanjing Medical University
NCT07064746
Recruiting
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
Neuroblastoma (NB)
NCT07306988 Phase 4
Recruiting
Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.
HELICOBACTER PYLORI INFECTIONS
NCT07195500
Recruiting
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
Neuroblastoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology